Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Ultragenyx Pharmaceutical (NASDAQ:RARE)

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Ultragenyx Pharmaceutical (NASDAQ:RARE)

NOVATO, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 48,731 restricted stock units of the company's common stock to 26 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board …

Ultragenyx Distributes Nearly 50,000 RSUs in Latest Employee Inducement Package: Full Grant Details

Rare disease biotech grants equity to 26 new hires with 4-year vesting schedule. Compensation committee approved under Nasdaq Rule 5635(c)(4). See details.